Review: Executive functioning and cannabis use;Revisão: Funcionamento executivo e uso de maconha

Revista Brasileira de Psiquiatria

Volumn 30, Issue 1, 2008, Pages 69-76

  De Almeida, Priscila Previato ^a,d   Novaes, Maria Alice Fontes Pinto ^a   Bressan, Rodrigo Affonseca ^a   De Lacerda, Acioly Luiz Tavares ^a,b,c  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Instituto Sinapse de Neurocie ncias Clínicas   (Brazil)

^c Centro de Pesquisa e Ensaios Clínicos Sinapse Bairral

^d NONE   (Brazil)

Author keywords

Cannabis; Cognition; Frontal lobe; Neuropsychology; Review literature

Indexed keywords

TETRAHYDROCANNABINOL;

BRAIN FUNCTION; CANNABIS ADDICTION; CONCEPT FORMATION; DATA BASE; DECISION MAKING; FRONTAL LOBE; HUMAN; IMPULSIVENESS; MEDLINE; MENTAL PERFORMANCE; MENTAL TASK; NEUROPSYCHOLOGY; PLANNING; REVIEW; TASK PERFORMANCE;

ATTENTION; CANNABINOIDS; COGNITION; COGNITION DISORDERS; CONCEPT FORMATION; DECISION MAKING; FRONTAL LOBE; HUMANS; IMPULSIVE BEHAVIOR; MARIJUANA ABUSE; MARIJUANA SMOKING; NEUROPSYCHOLOGICAL TESTS; TETRAHYDROCANNABINOL;

EID: 41949115098     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-44462008000100013     Document Type: Review

References (43)

1. Watson SJ, Benson JA, Joy JE. Marijuana and medicine: assessing the science base: a summary of the 1999 Institute of Medicine report. Arch Gen Psychiatry. 2000;57(6):547-52.
2. Hall W, Pacula RL. Cannabis use and dependence: public health and public policy. Cambrigde University Press; 2003.
3. Galduroz JC, Noto AR, Nappo SA, Carlini EA. Trends in drug use among students in Brazil: analysis of four surveys in 1987, 1989, 1993 and 1997. Braz J Med Biol Res. 2004;37(4):523-31.
4. Carlini EA, Galduróz JC, Noto AR, Nappo SA. I Levantamento domiciliar sobre o uso de drogas psicotrópicas no Brasil: estudo envolvendo as 107 maiores cidades do país. CEBRID: UNIFESP; 2002.
5. Carlini EA. The good and the bad effects of (-) trans-delta-9- tetrahydrocannabinol (Delta(9)-THC) on humans. Toxicon. 2004;44(4):461-7.
6. Grant I, Gonzalez R, Carey CL, Natarajan L, Wolfson T. Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study. J Int Neuropsychological Soc. 2003;9(5):679-89.
7. Hall W, Solowij N. Adverse effects of cannabis. Lancet. 1998;352(9140):1611-6.
8. Lezak MD. Neuropsychological Assessment. 3a. edição. New York: Oxford University Press; 1995.
9. Saboya E, Franco CA, Mattos P. Relationship among cognitive processes in executive functions. J Bras Psiquiatr. 2002;51(2):91-100.
10. Goldberg E. O cérebro executivo: lobos frontais e a mente civilizada. Rio de Janeiro: Ed. Imago; 2002.
11. Rogers RD, Everitt BJ, Baldacchino A, Blackshaw AJ, Swainson R, Wynne K, Baker NB, Hunter J, Carthy T, Booker E, London M, Deakin JF, Sahakian BJ, Robbins TW. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophandepleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology. 1999;20(4):322-39.
12. Kaplan H I, Saddock B J, Grebb J A. Compêndio de Psiquiatria Clínica. 7a edição. Porto Alegre: Artes Médicas; 1997.
13. Verdejo-Garcia AJ, Lopez-Torrecillas F, Aguilar de Arcos F, Perez-Garcia M. Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis. Addict Behav. 2005;30(1):89-101.
14. Verdejo-García A, Rivas-Pérez C, López-Torrecillas F, Pérez-García M. Impacto de los deterioros neuropsicoló gicos asociados al consumo de sustancias sobre la práctica clínica con drogodependientes. Adicciones. 2002;14(3):1-26.
15. Verdejo-Garcia AJ, Rivas-Perez C, Lopez-Torrecillas F, Perez-Garcia M. Differential impact of severity of drug use on frontal behavioral symptoms. Addict Behav. 2006;31(8):1373-82.
16. Rogers RD, Robbins TW. Investigating the neurocognitive deficits associated with chronic drug misuse. Curr Opin Neurobiol. 2001;11(2):250-7.
17. Pope HG Jr. Cannabis, cognition, and residual confounding. JAMA. 2002;287(9):1172-4.
18. Verdejo-García A, López-Torrecillas F, Giménez CO, Pérez-García M. Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse. Neuropsychol Rev. 2004;14(1):1-41.
19. Howieson DB, Lezak MD. The neuropsychological evaluation. In: Yudofsky SC, Hales RE. Textbook of Neuropsychiatry. Washington: American Psychiatry Press; 1992.
20. Fuster JM. The prefrontal cortex: anatomy, physiology and neuropsychology of the frontal lobe. 3rd edition. Philadelphia: Lippincott-Raven; 1997.
21. Hart CL, van Gorp W, Haney M, Foltin RW, Fischman MW. Effects of acute smoked marijuana on complex cognitive performance. Neuropsychopharmacology. 2001; 25(5):757-65.
22. McDonald J, Schleifer L, Richards JB, de Wit H. Effects of THC on behavioral measures of impulsivity in humans. Neuropsychopharmacology. 2003;28(7):1356-65.
23. Ramaekers JG, Kauert G, van Ruitenbeek P, Theunissen EL, Schneider E, Moeller MR. High-potency marijuana impairs executive function and inhibitory motor control. Neuropsychopharmacology. 2006;31(10):2296-303.
24. Saboya E, Franco CA, Mattos P. Relationship among cognitive processes in executive functions. J Bras Psiquiatr. 2002;51(2):91-100.
25. Maurin RK. Executive functioning in neuropsychiatric disorders: an overview. Semin Clin Neuropsychiatry. 1999;4(1):2-4.
26. Cohen MJ, Rickles WH Jr. Performance on a verbal learning task by subjects of heavy past marijuana usage. Psychopharmacologia. 1974;37(4):323-30.
27. Solowij N. Cannabis and cognitive functioning. Cambridge, UK: Cambridge University Press; 1998.
28. Solowij N, Stephens RS, Roffman RA, Babor T, Kadden R, Miller M, Christiansen K, McRee B, Vendetti J. Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA. 2002;287(9):1123-31.
29. Pope HG Jr, Yurgelun-Todd D. The residual cognitive effects of heavy marijuana use in college students. JAMA. 1996;275(7):521-7.
30. Pope HG Jr, Gruber AJ, Hudson JI, Huestis MA, Yurgelun-Todd D. Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry. 2001;58(10):909-15.
31. Pope HG Jr, Gruber AJ, Hudson JI, Cohane G, Huestis MA, Yurgelun-Todd D. Early-onset cannabis use and cognitive deficits: what is the nature of the association? Drug Alcohol Depend. 2003;69(3):303-10.
32. Bolla KI, Brown K, Eldreth D, Tate K, Cadet JL. Dose-related neurocognitive effects of marijuana use. Neurology. 2002;59(9):1337-43.
33. Lyons MJ, Bar JL, Panizzon MS, Toomey R, Eisen S, Xian H, Tsuang MT. Neuropsychological consequences of regular marijuana use: a twin study. Psychol Med. 2004;34(7):1239-50.
34. Jones RT. Cannabis tolerance and dependence. In: Cannabis and health hazards. Toronto: Addiction Research Foundation; 1983.
35. Maykut MO. Health consequences of acute and chronic marihuana use. Prog Neuropsychopharmacol Biol Psychiatry. 1985;9(3):209-38.
36. Spreen O, Strauss EA. Compedium of neuropsychoilogical tests: administration, norms and commentary. New York: Oxford University Press; 1991.
37. Lundqvist T. Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacol Biochem Behav. 2005;81(2):319-30.
38. Miceli G, Caltagirone C, Gainotti G, Masullo C, Silveri MC. Neuropsychological correlates of localized cerebral lesions in nonaphasic brain damaged patients. J Clin Neuropsychol. 1981;3:53-63.
39. Ponto LL. Challenges of marijuana research. Brain. 2006;129(Pt 5):1081-3.
40. Chang L, Yakupov R, Cloak C, Ernst T. Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation. Brain. 2006;129(Pt 5):1096-112.
41. Kanayama G, Rogowska J, Pope HG, Gruber SA, Yurgelun-Todd DA. Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study. Psychopharmacology (Berl). 2004;176(3-4):239-47.
42. Eldreth DA, Matochik JA, Cadet JL, Bolla KI. Abnormal brain activity in prefrontal brain regions in abstinent marijuana users. Neuroimage. 2004;23(3):914-20.
43. Volkow ND, Fowler JS, Wang GJ. The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies. Neuropharmacology. 2004;47(Suppl 1):3-13.